Life Science Investing TScan Therapeutics to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference
Life Science Investing TScan Therapeutics Reaches Agreement with FDA on Pivotal Study Design for TSC-101 and Announces Strategic Prioritization to Advance TSC-101 and Extend Cash Runway into H2 2027
Life Science Investing TScan Therapeutics Announces Upcoming Oral and Poster Presentations at the American College of Rheumatology Convergence 2025
CHARBONE annonce la nomination de Patrick Cuddihy au poste de Vice-president principal - Affaires strategiques
NevGold Announces Up to 85% Antimony Recovery From Positive Phase II Metallurgical Testwork at Oxide Gold-Antimony Limo Butte Project in Nevada
